Anti-retroviral therapy with protease inhibitors decreases virulence enzyme expression in vivo by Candida albicans without selection of avirulent fungus strains or decreasing their anti-mycotic susceptibility - De Bernardis, Flavia; Tacconelli, Evelina; Mondello, Francesca; Cataldo, Adriana; Arancia, Silvia; Cauda, Roberto; Cassone, Antonio (FEMS immunology and medical microbiology, 2004)
Keywords: Adult; AIDS-Related Opportunistic Infections - drug therapy; Antiretroviral drugs; Antiretroviral Therapy, Highly Active; Aspartic Acid Endopeptidases - metabolism; Biological and medical sciences; Biotypes; Candida; Candida - drug effects; Candida - enzymology; Candida - isolation & purification; Candida - pathogenicity; Candida albicans; Candidiasis, Oral - drug therapy; Cross-Sectional Studies; Female; Fundamental and applied biological sciences. Psychology; Fungi; Highly active antiretroviral therapy; HIV; HIV Infections - drug therapy; HIV Infections - immunology; HIV Protease Inhibitors - therapeutic use; Human immunodeficiency virus; Humans; Longitudinal Studies; Male; Microbiology; Miscellaneous; Mycology; Oral cavity; Oropharynx - microbiology; Protease; Protease inhibitors; Proteinase; Proteinase inhibitors; Proteinase secretion; Reverse Transcriptase Inhibitors - therapeutic use; Saliva - microbiology; Virulence; Viruses; Biotypes; Proteinase secretion; Proteinase inhibitors; HIV; Candida; Candida albicans; Yeast; Microbiology; Enzyme; Virulence; Enzyme inhibitor; Fungi; Avirulent strain; Sensitivity; Immunology; Treatment; Antiviral; Fungi Imperfecti; Protease inhibitor; Thallophyta